Literature DB >> 3170132

Acute leukemia occurring after radiotherapy and chemotherapy with a nitrosourea, PCNU.

K V Shepard1, R Larson, M M Le Beau, L Leichman, B Levin.   

Abstract

Secondary acute leukemias can occur in patients who have been treated with chemotherapy. Several reports have shown that treatment with nitrosoureas can result in secondary leukemia, but this is the first report implicating the investigational drug PCNU as a cause. This case is unique because of the cytogenetic findings, the short latency period between the chemotherapy and the diagnosis of leukemia, and the successful treatment of the leukemia with high-dose cytarabine (ara-C).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3170132     DOI: 10.1007/bf00195370

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.850


  11 in total

1.  Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Ann Intern Med       Date:  1985-10       Impact factor: 25.391

Review 2.  Incidence, previous treatment and chromosome characteristics of secondary acute non-lymphocytic leukemia.

Authors:  J Pedersen-Bjergaard
Journal:  Cancer Treat Rev       Date:  1985-03       Impact factor: 12.111

3.  Risk of leukaemia associated with cancer chemotherapy.

Authors:  J M Whitehouse
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-26

4.  Phase II trial of PCNU in non-small cell lung cancer.

Authors:  L A Kalman; M B Stoopler; E S Casper; D P Kelsen; M G Kris; R J Gralla
Journal:  Cancer Treat Rep       Date:  1983-09

5.  Phase II study of PCNU in colorectal carcinoma.

Authors:  E P Mitchell; J Y Killen; F P Smith; L L Willis; P S Schein; P V Woolley
Journal:  Cancer Treat Rep       Date:  1981 Nov-Dec

6.  Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. A unique cytogenetic-clinicopathological association.

Authors:  M M Le Beau; R A Larson; M A Bitter; J W Vardiman; H M Golomb; J D Rowley
Journal:  N Engl J Med       Date:  1983-09-15       Impact factor: 91.245

7.  Abnormalities of chromosome 16 in association with acute myelomonocytic leukemia and dysplastic bone marrow eosinophils.

Authors:  D E Hogge; S Misawa; N Z Parsa; A Pollak; J R Testa
Journal:  J Clin Oncol       Date:  1984-06       Impact factor: 44.544

8.  Adjuvant therapy of colon cancer--results of a prospectively randomized trial.

Authors: 
Journal:  N Engl J Med       Date:  1984-03-22       Impact factor: 91.245

9.  Acute myelomonocytic leukemia with abnormal eosinophils and inv(16) or t(16;16) has a favorable prognosis.

Authors:  R A Larson; S F Williams; M M Le Beau; M A Bitter; J W Vardiman; J D Rowley
Journal:  Blood       Date:  1986-12       Impact factor: 22.113

10.  Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7.

Authors:  M M Le Beau; K S Albain; R A Larson; J W Vardiman; E M Davis; R R Blough; H M Golomb; J D Rowley
Journal:  J Clin Oncol       Date:  1986-03       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.